<?xml version="1.0" encoding="UTF-8"?>
<ref id="B127-jcm-09-01917">
 <label>127.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <collab>OncoArendi Therapeutics (OAT)</collab>
  </person-group>
  <source>Drug Candidate OATD-01 May Find Use in Treatment of Pulmonary Fibrosis in Patients Who Have Survived a New Coronavirus Infection (COVID-19)</source>
  <publisher-name>OncoArendi Therapeutics (OAT)</publisher-name>
  <publisher-loc>Warsaw, Poland</publisher-loc>
  <year>2020</year>
 </element-citation>
</ref>
